The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
|Articles|March 2, 2020
- Pharmaceutical Technology-03-02-2020
- Volume 44
- Issue 3
Double Planetary Mixer
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system.
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system.
The sanitary four-gallon Double Planetary Mixer & Discharge System Model DPM/DS-4S (pictured) includes type 316 stainless steel on the interior and exterior, electropolished to a 150-grit (#4) finish. The mixer’s jacketed mixing vessel and high viscosity blades are equipped to produce thick gels, pastes, putties, and other semi-solids at precise temperatures. The sealed gearbox and stirrer shafts guarantee complete cleanability and eliminate cross-contamination between batches.
Articles in this issue
over 6 years ago
Drug Production Draws Multiple Contendersover 6 years ago
Coronavirus Response: Reaction or New Reality?over 6 years ago
Embracing Change Managementover 6 years ago
Isolator Head for Microbial Air Samplingover 6 years ago
Compressor-Free Plate Sealerover 6 years ago
Double Clamshell Barrel Continuous Processorover 6 years ago
Challenges in Clinical Manufacturing for Topical Drugsover 6 years ago
Stability Testing: The Crucial Development Stepover 6 years ago
Keeping Toxicity to a Minimumover 6 years ago
Noteworthy Historical Cases of Adverse Drug ReactionsRelated to this article
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Swedish biotech companies have a broad and varied product pipeline that is attracting attention from venture capitalists and pharmaceutical companies.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
Jaenisch, Muraru, and Pandey debate whether AI "slop" is infiltrating pharma SOPs and deviation reports and who should catch it first.
Trending on Pharmaceutical Technology
1
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
Sweden, a Powerhouse for Early Stage Innovation
4
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
5